Risk stratification for sudden cardiac death in patients with non-ischemic dilated cardiomyopathy

Karthik Shekha1, Joydeep Ghosh, Deepak Thekkoott

  • 1Department of Cardiology and Clinical Electrophysiology, Maimonides Medical Center (Mount Sinai Health System), Brooklyn, New York 11219, USA.

Insights

Non-ischemic dilated cardiomyopathy (NIDCM) shares symptoms with heart failure and can lead to sudden cardiac death (SCD). Identifying high-risk NIDCM patients for targeted interventions remains a clinical challenge.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Pathology

Background:

  • Non-ischemic dilated cardiomyopathy (NIDCM) is a myocardial disorder with diverse causes.
  • NIDCM presents with heart failure symptoms and, rarely, sudden cardiac death (SCD).
  • Its manifestations mimic ischemic dilated cardiomyopathy (IDCM).

Purpose of the Study:

  • To review existing data on risk stratification in NIDCM.
  • To analyze the clinical implications of NIDCM risk stratification.
  • To identify patients at high risk for SCD despite medical management.

Main Methods:

  • Systematic review of current literature on NIDCM.
  • Analysis of risk stratification strategies for NIDCM.
  • Evaluation of clinical data regarding patient outcomes.

Main Results:

  • A subset of NIDCM patients faces a significant risk of SCD from ventricular arrhythmias.
  • Accurate identification of high-risk NIDCM individuals is challenging.
  • Current risk stratification methods and their practical applications are under examination.

Conclusions:

  • Effective risk stratification is crucial for managing NIDCM patients prone to SCD.
  • Targeted interventions can potentially improve outcomes and reduce healthcare costs associated with ICDs.
  • Further research is needed to refine risk assessment and guide clinical practice in NIDCM.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
696
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
806
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
766
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
789
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
930
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
742